CEO

 

HOSTED BY:     Jefferies Investment Bank

CEO OF THE YEAR (JOINT AWARD)


This award recognises both a private and publicly-listed company CEO that has demonstrated truly outstanding and exemplary leadership in their respective companies. 
 
Qualifying criteria
 
- Open to CEOs of privately and publicly owned life science companies
- Period to be judged review is between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:
 
- Career achievements and leadership qualities
- How the has CEO created value for shareholders and investors
- What the CEOs greatest achievements were in this period
- Creation of new partnerships / leveraging existing partnerships
- What the CEO has done to influence and advance the wider life science industry
 
 
 
2019 WINNERS
 
 
 
 
 
(L-R) Ellie Taylor, Emcee, Sean Marett, CBO, BioNTech collecting on behalf of Ugur Sahin, CEO, BioNTech and Gil Bar Nahum, Managing Director, Jefferies.
 
 
 
 
(L-R) Ellie Taylor, Emcee, Onno van de Stolpe, CEO, Galapagos and Gil Bar Nahum, Managing Director, Jefferies.
 
 
2019 HIGHLY COMMENDED
 
 
 
 
 
 

ALL 2019 PRIVATE AND PUBLIC COMPANY CEO FINALISTS

 

Catherine Pickering

CATHERINE PICKERING, CEO, IONCTURA

SWITZERLAND
Erik van den Berg

ERIK VAN DEN BERG, CEO, AM-PHARMA

THE NETHERLANDS
Mark Altmeyer

MARK ALTMEYER, CEO, ARVELLE THERAPEUTICS

SWITZERLAND
Ugur Sahin

UGUR SAHIN, CEO, BIONTECH

GERMANY
Emma Walmsley

EMMA WALMSLEY, CEO, GSK

UNITED KINGDOM
Jan Møller Mikkelsen

JAN MØLLER MIKKELSEN, PRESIDENT AND CEO, ASCENDIS PHARMA

DENMARK
Jan van de Winkel

JAN VAN DE WINKEL, PRESIDENT AND CEO, GENMAB

THE NETHERLANDS
Onno van de Stolpe

ONNO VAN DE STOLPE, CEO, GALÁPAGOS

BELGIUM

BUY TICKETS AND TABLES